- Ticker iNav Bloomberg: IVEUREUR
- Exchange ticker: VEUR
- Bloomberg: VEUR IM
- ISIN: IE00B945VV12
- MEX ID: VIEURV
- Reuters: VEUR.MI
- SEDOL: BGSF280
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
As at 30 kwi 2026
Please note Beta and R-squared data will only display for funds with 3 full years of history.
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
| Fundamentals | Fund | Benchmark | As at |
|---|---|---|---|
| Number of stocks | 514 | 497 | 30 kwi 2026 |
| Median market capital | 75,4 B | 75,4 B | 30 kwi 2026 |
| 17,5 x | 17,5 x | 30 kwi 2026 | |
| 2,3 x | 2,4 x | 30 kwi 2026 | |
| 13,8% | 13,8% | 30 kwi 2026 | |
| 12,4% | 12,4% | 30 kwi 2026 | |
| Portfolio turnover rate | -17,7% | — | 31 mar 2026 |
As at 30 kwi 2026
| Country | Region | Fund | Benchmark | Variance +/- |
|---|---|---|---|---|
| Wielka Brytania | Europa | 23,50% | 23,49% | 0,01% |
| Francja | Europa | 14,79% | 14,79% | 0,00% |
| Szwajcaria | Europa | 14,34% | 14,34% | 0,00% |
| Niemcy | Europa | 13,64% | 13,63% | 0,01% |
| Holandia | Europa | 7,73% | 7,73% | 0,00% |
| Hiszpania | Europa | 5,84% | 5,84% | 0,00% |
| Włochy | Europa | 5,62% | 5,62% | 0,00% |
| Szwecja | Europa | 5,17% | 5,17% | 0,00% |
| Dania | Europa | 2,47% | 2,47% | 0,00% |
| Finlandia | Europa | 1,93% | 1,93% | 0,00% |
| Belgia | Europa | 1,73% | 1,73% | 0,00% |
| Norwegia | Europa | 1,07% | 1,07% | 0,00% |
| Polska | Europa | 0,75% | 0,75% | 0,00% |
| Irlandia | Europa | 0,55% | 0,55% | 0,00% |
| Austria | Europa | 0,54% | 0,54% | 0,00% |
As at 30 kwi 2026
| Holding name | % of market value | Sector | Region | Market value | Shares |
|---|---|---|---|---|---|
| ASML Holding NV | 3,85142% | Technology | NL | 265 076 217,60 € | 216 849 |
| HSBC Holdings PLC | 2,17932% | Financials | GB | 149 992 601,05 € | 9 598 490 |
| Roche Holding AG | 1,98180% | Health Care | CH | 136 398 322,50 € | 392 995 |
| Novartis AG | 1,96968% | Health Care | CH | 135 564 085,92 € | 1 073 031 |
| AstraZeneca PLC | 1,96692% | Health Care | GB | 135 374 483,00 € | 837 857 |
| Nestle SA | 1,80079% | Consumer Staples | CH | 123 940 080,48 € | 1 438 338 |
| Shell PLC | 1,78091% | Energy | GB | 122 571 803,75 € | 3 181 364 |
| Siemens AG | 1,50608% | Industrials | DE | 103 656 622,00 € | 410 440 |
| Banco Santander SA | 1,23390% | Financials | ES | 84 923 918,10 € | 8 181 495 |
| SAP SE | 1,21466% | Technology | DE | 83 599 644,00 € | 574 568 |
-
Inception date
21 maj 2013
Listing date
18 sty 2019
| Date | NAV (EUR) | Market price (EUR) |
|---|---|---|
| 18 maj 2026 | 47,5619 € | 47,6500 € |
| 15 maj 2026 | 47,2474 € | 47,2400 € |
| 14 maj 2026 | 47,9648 € | 48,1200 € |
| 13 maj 2026 | 47,5684 € | 47,5600 € |
| 12 maj 2026 | 47,1930 € | 47,2750 € |
| 11 maj 2026 | 47,6572 € | 47,7650 € |
| 08 maj 2026 | 47,5767 € | 47,6350 € |
| 07 maj 2026 | 47,8799 € | 47,9550 € |
| 06 maj 2026 | 48,3986 € | 48,4800 € |
| 05 maj 2026 | 47,3164 € | 47,4100 € |
Distribution frequency
Quarterly
Historical performance 30 kwi 2026
2,69%
| Type | Distribution amount (per unit) | Ex-dividend date | Registration date | Payable date |
|---|---|---|---|---|
| Income | 0,1815 € | 19 mar 2026 | 20 mar 2026 | 01 kwi 2026 |
| Income | 0,1676 € | 18 gru 2025 | 19 gru 2025 | 31 gru 2025 |
| Income | 0,1609 € | 18 wrz 2025 | 19 wrz 2025 | 01 paź 2025 |
| Income | 0,7630 € | 19 cze 2025 | 20 cze 2025 | 02 lip 2025 |
| Income | 0,1872 € | 20 mar 2025 | 21 mar 2025 | 02 kwi 2025 |
| Income | 0,1542 € | 12 gru 2024 | 13 gru 2024 | 27 gru 2024 |
| Income | 0,1605 € | 12 wrz 2024 | 13 wrz 2024 | 25 wrz 2024 |
| Income | 0,7398 € | 13 cze 2024 | 14 cze 2024 | 26 cze 2024 |
| Income | 0,1452 € | 14 mar 2024 | 15 mar 2024 | 27 mar 2024 |
| Income | 0,1332 € | 14 gru 2023 | 15 gru 2023 | 27 gru 2023 |
Listed currencies: GBP, EUR, CHF, USD, MXN
Base currency: EUR
Exchanges: London Stock Exchange, NYSE Euronext - Amsterdam, SIX Swiss Exchange, Deutsche Boerse, Bolsa Mexicana De Valores, Borsa Italiana S.p.A.